Arvelle Therapeutics
ExitedArvelle Therapeutics is tracked in the Tech.eu funding database. Based in Basel, Switzerland; active in Healthtech. Acquired by Angelini Pharma in 2021. Data as of Nov 2026.
Basel, Switzerlandwww.bexio.com ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Jan 2021
Value
€784M
Acquiror
Angelini Pharma (Italy)